BAX Baxter International Inc stock chart & analysis
Conviction 40HealthcareScan · Fri, Nov 6, 2026Baxter International Inc (BAX) closed at $25.79 (+0.55%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 56, RS Rating 90, -14.1% from its 52-week high, +34.9% year to date. Sector: Healthcare · Surgical & Medical Instruments & Apparatus.
Financials as of Wed, Sep 30, 2026 · quarterly.
BAX technical analysis
Trend
BAX is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 5.2% above the 50-day ($24.50) and 20.0% above the 200-day ($21.48). ADX(14) at 18 points to a weak trend — more range than direction. It meets 7 of 8 trend-template criteria.
Momentum
RSI(14) is 56, in the bullish half of its range. MACD crossed above its signal line 2 sessions ago. Its RS Rating of 90 puts its weighted 12-month performance ahead of about 90% of the US market.
Volume and volatility
Volume on the latest session ran 0.7× its 20-day average. It trades about $187.0M a day on average. ATR(14) is $1.08, 4.2% of price — its typical daily range.
Key levels
The chart pattern's support is $22.53 and its resistance $26.59. The 52-week range is $15.73 to $30.00; price is 14.1% below the high and 63.9% above the low. The VWAP anchored at the 52-week high is $25.22, below price.
Performance
BAX returned +12.1% (1 week), +7.9% (1 month), -7.2% (3 months), +43.3% (6 months), +43.6% (1 year), +34.9% (year to date).
About Baxter International Inc
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Surgical & Medical Instruments & Apparatus · Listed 1961 · 37,500 employees
Congress activity
Disclosed STOCK Act trades in BAX · 5 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Lisa McClain house · MI · traded 2025-10-30 | Sell | $1K–$15K | 2025-10-30 | 2025-11-01 | |
Lisa McClain house · R · MI · traded 2025-09-25 | Buy | $1K–$15K | 2025-09-25 | 2025-10-22 | |
Lisa McClain house · R · MI · traded 2025-08-04 | Sell | $1K–$15K | 2025-08-04 | 2025-09-12 | |
Lisa McClain house · R · MI · traded 2025-07-22 | Buy | $1K–$15K | 2025-07-22 | 2025-08-13 | |
 Rob Bresnahan house · PA · traded 2025-05-15 | Buy | $1K–$15K | 2025-05-15 | 2025-06-09 |
Insider activity
SEC Form 4 transactions in BAX
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Teaff James President, CCS · Common Stock, $1 par value · 2026-06-02 | Tax | 321 | $6K | 2026-06-02 | 2026-06-03 |
Wallace Steven P. President, Adv. Surgery · Common Stock, $1 par value · 2026-06-02 | Tax | 153 | $3K | 2026-06-02 | 2026-06-03 |
Zielinski Anita A SVP, Interim CFO, CAO & Cntrlr · Common Stock, $1 par value · 2026-06-01 | Grant | 13.43K | $0 | 2026-06-01 | 2026-06-03 |
McDonnell Michael R. Director · Common Stock, $1 par value · 2026-05-05 | Grant | 12.84K | $0 | 2026-05-05 | 2026-05-07 |
Wendell Amy McBride Director · Common Stock, $1 par value · 2026-05-05 | Grant | 12.84K | $0 | 2026-05-05 | 2026-05-07 |
MORRISON PATRICIA Director · Common Stock, $1 par value · 2026-05-05 | Grant | 12.84K | $0 | 2026-05-05 | 2026-05-07 |
Shafer David Brent Director · Common Stock, $1 par value · 2026-05-05 | Grant | 12.84K | $0 | 2026-05-05 | 2026-05-07 |
Wilkes David S. Director · Common Stock, $1 par value · 2026-05-05 | Grant | 12.84K | $0 | 2026-05-05 | 2026-05-07 |
Ampofo William A. II Director · Common Stock, $1 par value · 2026-05-05 | Grant | 12.84K | $0 | 2026-05-05 | 2026-05-07 |
Craig Jeffrey A Director · Common Stock, $1 par value · 2026-05-05 | Grant | 12.84K | $0 | 2026-05-05 | 2026-05-07 |
SEC filings
EDGAR filings in BAX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.